AdaptHealth Posts $820.3M Q3 Revenue (+1.8% YoY) as Q4 Earnings Loom
AdaptHealth exceeded forecasts with $820.3 million in Q3 revenue, up 1.8% year-on-year, while delivering EPS in line with estimates ahead of its Q4 report. Analysts predict a 3.3% revenue decline for Q4, reflecting potential headwinds in the healthcare services sector.
1. Upcoming Q4 Earnings Preview
AdaptHealth will report Q4 results before the bell this Tuesday, with consensus forecasting a 3.3% year-on-year revenue decline. Analysts have largely maintained their estimates over the past 30 days, indicating confidence in the company’s ability to navigate near-term challenges.
2. Q3 Revenue Beat and EPS Results
In the prior quarter, AdaptHealth delivered $820.3 million in revenue, a 1.8% increase year-on-year that topped analyst projections, while EPS matched consensus estimates. The mixed outcome underscores strengths in sales growth alongside margin pressure.
3. Peer Performance Context
Brookdale’s Q4 revenues fell 3.4% year-on-year, missing estimates by 1.7% and triggering a 9.7% stock decline, whereas Guardant Health reported a 39.4% revenue surge, beating forecasts by 3.5% but still saw its share price dip 3.1%. These divergent results offer insight into sector variability.
4. Outlook and Analyst Sentiment
The 2025 outlook for AdaptHealth is clouded by potential trade policy shifts and corporate tax debates that could dampen business confidence. Despite sector underperformance—down 3.4% on average over the past month—AdaptHealth has outpaced peers and holds an average analyst price target of $13.38.